×
About 21,780 results

ALLMedicine™ Irritable Bowel Syndrome Center

Research & Reviews  9,599 results

Specific and common mediators of gastrointestinal symptom improvement in patients under...
https://doi.org/10.1037/ccp0000648
Journal of Consulting and Clinical Psychology; Lackner JM, Jaccard J

Jun 14th, 2021 - Objective: This study sought to characterize change mechanisms that underlie gastrointestinal (GI) symptom improvement in IBS patients undergoing two dosages of CBT for IBS as compared to a nondirective education/support (EDU) condition. Method: D...

Early adverse life events and post-traumatic stress disorder in patients with constipat...
https://doi.org/10.1111/nmo.14195
Neurogastroenterology and Motility : the Official Journal... Hendrix J, Ranginani D et. al.

Jun 14th, 2021 - Early adverse life events (EALs) and post-traumatic stress disorder (PTSD) are associated with irritable bowel syndrome (IBS). Disordered defecation (DD) presents with symptoms of IBS or functional constipation (FC) and is associated with psycholo...

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction prot...
https://doi.org/10.1371/journal.pone.0252930
PloS One; Ivashkin V, Poluektov Y et. al.

Jun 11th, 2021 - Irritable bowel syndrome (IBS) is a pathologic condition characterized by changes in gut microbiome composition, low-grade inflammation, and disruption of intestinal wall permeability. The interaction between the gut microbiome and the disease man...

Better response to low FODMAP diet in DGBI patients with pronounced hydrogen response t...
https://doi.org/10.1111/jgh.15573
Journal of Gastroenterology and Hepatology; Schindler V, Giezendanner S et. al.

Jun 9th, 2021 - Previous studies have shown a reduction of gastrointestinal symptoms in irritable bowel syndrome (IBS) patients following a low FODMAP diet (LFD). It remains unknown, which disorders of gut-brain interaction (DGBI) patients, would benefit most fro...

A Collaborative Effort to Advance Drug Development in Pediatric Constipation and Irrita...
https://doi.org/10.1097/MPG.0000000000003191
Journal of Pediatric Gastroenterology and Nutrition; Saps M, Nurko S et. al.

Jun 6th, 2021 - Pediatric functional gastrointestinal disorders including irritable bowel syndrome with constipation and functional constipation are common conditions in childhood, but no drugs are FDA approved for chronic use in pediatric patients with these dis...

see more →

Guidelines  37 results

Ardelyx Receives FDA Approval For Ibsrela® (Tenapanor), An NHE3 Sodium Transport Inhibitor, For The Treatment Of Irritable Bowel Syndrome With Constipation
http://ir.ardelyx.com/news-releases/news-release-details/ardelyx-receives-fda-approval-ibsrelar-tenapanor-nhe3-sodium

Sep 10th, 2019 - Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration h...

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant ...
https://doi.org/10.1053/j.gastro.2019.06.014
Gastroenterology Carrasco-Labra A, Lytvyn L et. al.

Jul 28th, 2019 - The evaluation of patients with chronic watery diarrhea represents a diagnostic challenge for clinicians because organic causes, including inflammatory bowel disease, microscopic colitis, and chronic infection, must be differentiated from function...

AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea an...
https://doi.org/10.1053/j.gastro.2019.07.004
Gastroenterology Smalley W, Falck-Ytter C et. al.

Jul 15th, 2019 - AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).|2019|Smalley W,Falck-Ytter C,Carrasco-Labra A,Wani S,Lytvyn L,|standards,diagnosis,etiology,p...

AGA Guideline on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
https://www.gastrojournal.org/article/S0016-5085(19)41083-4/fulltext?referrer=https%3A%2F%2Fwww.jwatch.org%2Fna49679%2F2019%2F08%2F09%2Ftesting-functional-diarrhea-and-diarrhea-predominant

Jul 10th, 2019 - This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults. The guideline was de...

Irritable Bowel Syndrome (IBS)
https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome

Mar 31st, 2019 - Irritable bowel syndrome (IBS) is a group of symptoms that occur together, including repeated pain in your abdomen and changes in your bowel movements, which may be diarrhea, constipation, or both. With IBS, you have these symptoms without any vis...

see more →

Drugs  509 results see all →

Clinicaltrials.gov  10,717 results

Specific and common mediators of gastrointestinal symptom improvement in patients under...
https://doi.org/10.1037/ccp0000648
Journal of Consulting and Clinical Psychology; Lackner JM, Jaccard J

Jun 14th, 2021 - Objective: This study sought to characterize change mechanisms that underlie gastrointestinal (GI) symptom improvement in IBS patients undergoing two dosages of CBT for IBS as compared to a nondirective education/support (EDU) condition. Method: D...

Early adverse life events and post-traumatic stress disorder in patients with constipat...
https://doi.org/10.1111/nmo.14195
Neurogastroenterology and Motility : the Official Journal... Hendrix J, Ranginani D et. al.

Jun 14th, 2021 - Early adverse life events (EALs) and post-traumatic stress disorder (PTSD) are associated with irritable bowel syndrome (IBS). Disordered defecation (DD) presents with symptoms of IBS or functional constipation (FC) and is associated with psycholo...

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction prot...
https://doi.org/10.1371/journal.pone.0252930
PloS One; Ivashkin V, Poluektov Y et. al.

Jun 11th, 2021 - Irritable bowel syndrome (IBS) is a pathologic condition characterized by changes in gut microbiome composition, low-grade inflammation, and disruption of intestinal wall permeability. The interaction between the gut microbiome and the disease man...

Better response to low FODMAP diet in DGBI patients with pronounced hydrogen response t...
https://doi.org/10.1111/jgh.15573
Journal of Gastroenterology and Hepatology; Schindler V, Giezendanner S et. al.

Jun 9th, 2021 - Previous studies have shown a reduction of gastrointestinal symptoms in irritable bowel syndrome (IBS) patients following a low FODMAP diet (LFD). It remains unknown, which disorders of gut-brain interaction (DGBI) patients, would benefit most fro...

A Collaborative Effort to Advance Drug Development in Pediatric Constipation and Irrita...
https://doi.org/10.1097/MPG.0000000000003191
Journal of Pediatric Gastroenterology and Nutrition; Saps M, Nurko S et. al.

Jun 6th, 2021 - Pediatric functional gastrointestinal disorders including irritable bowel syndrome with constipation and functional constipation are common conditions in childhood, but no drugs are FDA approved for chronic use in pediatric patients with these dis...

see more →

News  889 results

Severe IBS Symptoms Improved During COVID-19 Lockdowns
https://www.medscape.com/viewarticle/952011

May 26th, 2021 - Irritable bowel syndrome symptoms improved among patients who endured a prolonged COVID-19 lockdown in Argentina, a finding that was unexpected yet reaffirms the gut-brain connection in this gastrointestinal disorder, according to a coauthor of a ...

What's New in Updated BSG Guidelines on Managing Irritable Bowel Syndrome?
https://www.medscape.com/viewarticle/950427

May 3rd, 2021 - The British Society of Gastroenterology has published new guidelines on the management of irritable bowel syndrome (IBS). Here's a summary of the key recommendations: Diagnosis The National Institute for Health and Care Excellence (NICE) guideline...

IBD: Fecal Calprotectin's Role in Guiding Treatment Debated
https://www.medscape.com/viewarticle/942441

Dec 9th, 2020 - Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory Bowel Diseases 2020 Annual Meeting on Wednesda...

Fecal Microbiota Transplantation Reduces IBS Symptoms
https://www.medscape.com/viewarticle/935325

Aug 9th, 2020 - NEW YORK (Reuters Health) - Fecal microbiota transplantation (FMT) reduces symptoms of irritable bowel syndrome (IBS) in some patients, but the benefits wane over time, according to findings from a placebo-controlled randomized trial. "Although se...

Multidisciplinary Approach Bests Specialist Care for Functional GI Problems
https://www.medscape.com/viewarticle/935117

Aug 4th, 2020 - NEW YORK (Reuters Health) - For patients with irritable bowel syndrome and other functional gastrointestinal disorders, a multidisciplinary team approach was more effective and less costly than gastroenterologist-only care in an open-label, single...

see more →

Patient Education  29 results see all →